Ortin Global Ltd. Stock price: Live updates

₹13.75

-4.51% (-0.65)

Market Cap

₹12 Cr.

P/E

0.00

Key Ratios

Edit Ratio's

Market cap

12.00 Cr

Prom Holding

1.23 %

ROE (%)

ROCE (%)

-39.50

Div Yield (%)

Sales

0.19 Cr

OPM (%)

-452 %

Debt to Equity

0.13

Institutions

1.68 %

Individual < 2 lac

54.19 %

No. of Shareholders

11,452

Edit Ratio's

About

Ortin Laboratories is a pharmaceutical company focused on providing quality drugs and medicine… Read more

Low

52W Range

High

Timeline

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statement

Edit rows

Forensics

6 Yes

Positive for this company

1 Neutral

Neutral for this company

8 No

Negative for this company

1 No Data

Insufficient data to analyse

Accounting & Shareholding

Depreciation Effect

Depreciation accounting is not leading to increase in profits
Other Income

Other income is not affecting ratios of the company
Pledge

Promoters have not pledged a significant portion of their holding
Retail Holding

Retail has been selling the stock which is usually a good time to buy
Promoter Holding

Promoter has not sold any shares in the last 90 days
Contingent Liabilities

Company has significant contigent liabilities which can be risky
Revenue Recognition

Chances of aggressive revenue recognition - operating profit of company is not getting converted to cash and recievables rising faster than sales

Price & Performance

Capex vs ROCE

Roce of the company has increased over the last three years
Share price

Share price has increased over last 10 years due to earnings
Debt

Company might have issues servicing its debt
Working Capital

Company has significant working capital which is dragging its roce and roe
Sales Growth

Sales of the company has grown at a slow pace
Margin Stability

Margins of the company are volatile
ROCE Strength

Roce of the company is not consistently strong
Balance Sheet Strength

Balance sheet is weak and might have solvency issues
Current vs Historic Valuation

Unable to calculate due to limited data

Revenue mix

Product Wise Break-Up

Peer Comparison

FAQs on Ortin Global Ltd. Business

What does Ortin Global do?

Ortin Laboratories, known for quality drugs and medicines, operates a formulations unit meeting WHO GMP Standards. Certified for quality management, it markets products across India with good acceptance in the medical community.

Who are the competitors of Ortin Global?

Ortin Global major competitors are Shamrock Indl. Co, Colinz Laboratories, Beryl Drugs, Parmax Pharma, Saroja Pharma Ind, Unjha Formulations, Hind Bio Science.
Market Cap of Ortin Global is ₹12 Crs.
While the median market cap of its peers are ₹12 Crs.

Is Ortin Global financially stable compared to its competitors?

Ortin Global seems to be less financially stable compared to its competitors.
Altman Z score of Ortin Global is 1.74 and is ranked 5 out of its 8 competitors.

View FAQ's On Shareprice

Company Filing

	2026	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Annual Report	FY26	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Earnings Release
Investor Presentation
Conference Call
Conference Call SummaryCon Call Summary Powered by Gemini

Discussions & Analysis

Ideas Dashboard

Results

Timeline

Watchlist

Portfolio

Alerts

Stock Screener

Market

Raw Material

Ortin Global Ltd.

Ortin Global Ltd.

Key Ratios

About

Timeline

Company Timeline

Custom financial statement

Forensics

6 Yes

1 Neutral

8 No

1 No Data

Accounting & Shareholding

Depreciation Effect

Other Income

Pledge

Retail Holding

Promoter Holding

Contingent Liabilities

Revenue Recognition

Price & Performance

Capex vs ROCE

Share price

Debt

Working Capital

Sales Growth

Margin Stability

ROCE Strength

Balance Sheet Strength

Current vs Historic Valuation

Revenue mix

Product Wise Break-Up

UNLOCK PREMIUM

Peer Comparison

FAQs on Ortin Global Ltd. Business

What does Ortin Global do?

Who are the competitors of Ortin Global?

Is Ortin Global financially stable compared to its competitors?

Company Filing

Discussions & Analysis

SIGN UP FOR FREE